Teva Pharmaceuticals Industries Ltd., of Jerusalem, said data that demonstrates significant differences in biological and immunological effects between Copaxone (glatiramer acetate, GA) and a purported generic glatiramer acetate (GA), marketed in India, (Glatiramer, Natco Pharma Ltd., Hyderabad, India), with potential clinical ramifications were published in PLOS ONE.